A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers
NCT02858973 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 47
Last updated 2018-05-14
Summary
This is randomized, double-blind, placebo-controlled, multiple ascending dose study of Q203 in healthy volunteers conducted at one study center in the United States
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
Q203
- DRUG
Sponsors & Collaborators
-
Qurient Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2018-05-31
- Completion
- 2018-05-08
Countries
- United States
Study Locations
More Related Trials
-
A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers
NCT01392820 ·Status: COMPLETED ·Phase: PHASE1
-
AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00912353 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study of TD-0714 in Healthy Subjects
NCT02639078 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants
NCT03188783 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MHAB5553A in Healthy Volunteers
NCT02528903 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults
NCT05274659 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects
NCT00953888 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers
NCT06008652 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants
NCT06502379 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose Study of MT203
NCT02354599 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT04866160 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT03868540 ·Status: TERMINATED ·Phase: PHASE1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
NCT07219368 ·Status: RECRUITING ·Phase: PHASE1
-
A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants
NCT06532396 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants
NCT07281703 ·Status: RECRUITING ·Phase: PHASE1
-
Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers
NCT01638598 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy Subjects
NCT04532957 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy Volunteers
NCT01037725 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy Participants
NCT02015533 ·Status: WITHDRAWN ·Phase: PHASE1
-
This Study is Done in Healthy Chinese and Japanese Volunteers; it Looks at How BI 690517 is Taken up in the Body and How Well it is Tolerated
NCT03206632 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers
NCT00861718 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects
NCT02873156 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent
NCT01081821 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects
NCT02415790 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults
NCT03597217 ·Status: COMPLETED ·Phase: PHASE1